# Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Heinz Wiendl,Ralf Gold,Thomas Berger,Tobias Derfuß,Ralf A. Linker,Mathias Mäurer,Orhan Aktaş,Karl Baum,Martin Berghoff,Stefan Bittner,Andrew Chan,Adam Czapliński,Florian Deisenhammer,Franziska Di Pauli,Renaud Du Pasquier,Christian Enzinger,Elisabeth Fertl,Achim Gass,Klaus Gehring,Claudio Gobbi,Norbert Goebels,Michael Guger,Aiden Haghikia,Hans‐Peter Hartung,Fedor Heidenreich,Olaf Hoffmann,Boris Kallmann,Christoph Kleinschnitz,Luisa Klotz,Verena I. Leussink,Fritz Leutmezer,Volker Limmroth,Jan D. Lünemann,Andreas Lutterotti,Sven G. Meuth,Uta Meyding‐Lamadé,Michael Platten,Peter Rieckmann,Stephan Schmidt,Hayrettin Tumani,Frank Weber,Martin S. Weber,Uwe K. Zettl,Tjalf Ziemssen,Frauke Zipp,for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG) |
| Citations | 194 |
| DOI | 10.1177/17562864211039648 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.sagepub.com/doi/pdf/10.1177/17562864211039648 |
| OpenAlex ID | https://openalex.org/W3193418223 |
| PMID | 34422112 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Michael Guger](https://scholariq.org/researchers/michael-guger/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.